Your browser doesn't support javascript.
loading
Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy.
Girodon, François; Schaeffer, Céline; Cleyrat, Cédric; Mounier, Morgane; Lafont, Ingrid; Santos, Frédéric Dos; Duval, Aurélie; Vidal, Aurélie; Maynadié, Marc; Hermouet, Sylvie.
Affiliation
  • Girodon F; Laboratoire d'Hématologie, Hôpital du Bocage, CHU de Dijon, Dijon, France. francois.girodon@chu-dijon
Haematologica ; 93(11): 1723-7, 2008 Nov.
Article in En | MEDLINE | ID: mdl-18728027

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia Vera / Janus Kinase 2 / Thrombocythemia, Essential / Hydroxyurea Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2008 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia Vera / Janus Kinase 2 / Thrombocythemia, Essential / Hydroxyurea Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2008 Type: Article Affiliation country: France